4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-001859
Chief Financial Officer acquired 40,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rasbach Kyle Chief Financial Officer | 2025-01-17 | Grant or award | +40,875 | 40,875 | D | ||
| Derivatives | |||||||
| Rasbach Kyle Chief Financial Officer | 2025-01-17 | Grant or award · Stock Option (right to buy) | +245,250 | 245,250 | D | ||
Loading xslF345X05/form4-01222025_040101.xml…